Janssen-Cilag Gmbh - Company Review
Janssen-Cilag Gmbh - Company ReviewSummary
Janssen-Cilag GmbH (Janssen-Cilag), a subsidiary of Johnson & Johnson is a drug company that manufactres pharmaceutical products. The company’s products include doxorubicin, methylphenidate, daratumumab, decitabine, fentanyl, epoetin alfa, imbruvica, inuvair, and others. It offers treatment in the therapeutic areas of anesthesia, dermatology, gynecology, mycology, nephrology, psychiatry, HIV/AIDS, psoriasis arthritis, tuberculosis, anemia in kidney disease, epilepsy, and schizophrenia, among others. Janssen-Cilag offers services such as drug development, research and development, clinical trials, partnerships, transparency, sustainability, diagnostics services, healthcare innovation services. It partners with doctors, medical professional, and health industry. Janssen-Cilag is headquartered in Neuss, Germany.
This comprehensive company report of Janssen-Cilag Gmbh provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.